Company news
NeuroOne Medical Technologies Corporation news in 2022
NeuroOne Medical Technologies Corporation's news releases, calls and decks from 2022, newest first.
NeuroOne® Reports Fiscal Fourth Quarter and Full Fiscal Year 2022 Financial Results
December 21, 2022
NeuroOne® to Report Fourth Quarter and Fiscal Year 2022 Financial Results and Provide Corporate Update on December 13
December 7, 2022
NeuroOne® Successfully Completes Feasibility Study with its OneRF™ Ablation System
December 5, 2022
NeuroOne® Ships Initial Zimmer Biomet Order for its Evo® sEEG System for Less than 30 Day Use
November 29, 2022
NeuroOne® to Ring Nasdaq Stock Market Closing Bell on November 22
November 21, 2022
NeuroOne® Receives FDA 510(k) Clearance to Market its Evo® sEEG System for Less than 30 Day Use
October 24, 2022
NeuroOne Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 21, 2022
NeuroOne® Reports Third Quarter Fiscal Year 2022 Financial Results and Provides Corporate Update
August 10, 2022
NeuroOne® Submits Special 510(k) to FDA for Evo® sEEG Electrode
August 8, 2022
NeuroOne® to Report Third Quarter Fiscal Year 2022 Financial Results on August 11
August 3, 2022
NeuroOne® Announces $3.5 Million Accelerated Milestone Payment from Zimmer Biomet for Evo® sEEG Electrode
August 2, 2022
NeuroOne® Announces First Clinical Case Using Evo® sEEG Electrode
July 11, 2022
NeuroOne Provides Evo® sEEG Update
May 15, 2022
NeuroOne Reports Second Quarter Fiscal Year 2022 Financial Results and Provides Corporate Update
May 11, 2022
NeuroOne® to Report Second Quarter Fiscal Year 2022 Financial Results on May 12
May 2, 2022
NeuroOne® to Present its Disruptive Next-Generation Diagnostic Electrode Technology at the NobleCon18 Investor Conference on April 20, 2022
April 17, 2022
NeuroOne® Releases Successful Completion of Long-Term Stimulation Tests for its Novel Thin Film Platform Electrode Technology
March 1, 2022
NeuroOne Reports First Quarter Fiscal Year 2022 Financial Results and Provides Corporate Update
February 13, 2022
NeuroOne® Medical Technologies Corporation Releases Successful Long-Term Recording Test Data for its Novel Thin Film Platform Electrode Technology
February 7, 2022
NeuroOne Appoints Chad Wilhelmy, as Vice President of Quality Control and Regulatory Affairs
January 17, 2022
Calls in 2022
- NeuroOne Medical Technologies (NASDAQ:NMTC) Q4 2022 Earnings Call
Dec 13, 2022
Transcript - NeuroOne Medical Technologies (NASDAQ:NMTC) Q3 2022 Earnings Call
Aug 11, 2022
Transcript - NeuroOne Medical Technologies (NASDAQ:NMTC) Q2 2022 Earnings Call
May 12, 2022
Transcript - NeuroOne Medical Technologies (NASDAQ:NMTC) Q1 2022 Earnings Call
Feb 14, 2022
Transcript